Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats

Journal of Physiology

Volumn 589, Issue 10, 2011, Pages 2585-2596

  Camporez, João Paulo Gabriel ^a   Akamine, Eliana Hiromi ^a   Davel, Ana Paula ^a,b   Franci, Celso Rodrigues ^a   Rossoni, Luciana Venturini ^a   De Oliveira Carvalho, Carla Roberta ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; APOCYNIN; COPPER ZINC SUPEROXIDE DISMUTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PRASTERONE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; MENOPAUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ACETOPHENONES; ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; CARDIOVASCULAR AGENTS; DEHYDROEPIANDROSTERONE; ENDOTHELIUM, VASCULAR; FEMALE; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITROPRUSSIDE; OVARIECTOMY; OXIDATIVE STRESS; PHENYLEPHRINE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 79955977746     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.206078     Document Type: Article

References (47)

1. Aragno M, Mastrocola R, Alloatti G, Vercellinatto I, Bardini P, Geuna S, Catalano MG, Danni O & Boccuzzi G (2008). Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology 149, 380-388.
2. Aragno M, Mastrocola R, Catalano MG, Brignardello E, Danni O & Boccuzzi G (2004). Oxidative stress impairs skeletal muscle repair in diabetic rats. Diabetes 53, 1082-1088.
3. Aragno M, Mastrocola R, Medana C, Graziella M, Vercellinatto I, Danni O & Boccuzzi G (2006). Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes. Endocrinology 147, 5967-5974.
4. Aragno M, Tamagno E, Gatto V, Brignardello E, Parola S, Danni O & Boccuzzi G (1999). Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress. Free Radic Biol Med 26, 1467-1474.
5. Barrett-Connor E, Khaw KT & Yen S (1986). A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 315, 1519-1524.
6. Bhuiyan S & Fukunaga K (2010). Stimulation of Sigma-1 receptor by dehydroepiandrosterone ameliorates hypertension-induced kidney hypertrophy in ovariectomized rats. Exp Biol Med 235, 356-364.
7. Brignardello E, Runzo C, Aragno M, Catalano MG, Cassader M, Perin PC & Boccuzzi G (2007). Dehydroepiandrosterone administration counteracts oxidative imbalance and advanced glycation end product formation in type 2 diabetic patients. Diabetes Care 30, 2922-2927.
8. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ & Labarthe D (1995). Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25, 305-313.
9. Cai H & Harrison DG (2000). Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87, 840-844.
10. Campbell CS, Caperuto LC, Hirata AE, Araújo EP, Velloso LA, Saad MJ & Carvalho CRO (2004). The phosphatidylinositol/Akt/atypical PKC pathway is involved in the improved insulin sensitivity by DHEA in muscle and liver of rats in vivo. Life Sci 76, 57-70.
11. Celebi F, Yilmaz I, Aksoy H, Gümüş M, Taysi S, & Oren D (2004). Dehydroepiandrosterone prevents oxidative injury in obstructive jaundice in rats. J Int Med Res 32, 400-405.
12. Davel AP, Fukuda LE, De Sá LL, Munhoz CD, Scavone C, Sanz-Rosa D, Cachofeiro V, Lahera V & Rossoni LV (2008). Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta. Am J Physiol Heart Circ Physiol 295, H211-H219.
13. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R & Zeiher AM (1999). Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601-605.
14. Formoso G, Chen H, Kim J, Montagnani M, Consoli A & Quon MJ (2006). Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase-and mitogen-activated protein kinase-dependent pathways in vascular endothelium. Mol Endocrinol 20, 1153-1163.
15. Gutiérrez G, Mendoza C, Zapata E, Montiel A, Reyes E, Montaño LF & Lópes-Marure R (2007). Dehydroepiandrosterone inhibits the TNF-α-induced inflammatory response in human umbilical vein endothelial cells. Atherosclerosis 190, 90-99.
16. Han DH, Hansen PA, Chen MM & Holloszy JO (1998). DHEA treatment reduces fat accumulation and protects against insulin resistance in male rats. J Gerontol A Biol Sci Med Sci 53, B19-B24.
17. Hayashi T, Esaki T, Muto E, Kano H, Asai Y, Thakur NK, Sumi D, Jayachandran M & Iguchi A (2000). Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide. Arterioscler Thromb Vasc Biol 20, 782-792.
18. Hernanz R, Briones AM, Alonso MJ & Vila E, Salaices M (2004). Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin relaxation impairment after LPS in rat cerebral arteries. Am J Physiol Heart Circ Physiol 287, H225-H234.
19. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B & Vittinghoff E (1998). Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280, 605-613.
20. Ito K, Hirooka Y, Kimura Y, Sagara Y & Sunagawa K (2006). Ovariectomy augments hypertension through rho-kinase activation in the brain stem in female spontaneously hypertensive rats. Hypertension 48, 651-657.
21. Jacob MH, Janner DR, Jahn MP, Kucharski LC, Belló-Klein A & Ribeiro MFM (2009). DHEA effects on myocardial Akt signaling modulation and oxidative stress changes in aged rats. Steroids 74, 1045-1050.
22. Kimura M, Sudhir K, Jones M, Simpson E, Jefferis AM & Chin-Dusting JP (2003). Impaired acetylcholine-induced release of nitric oxide in the aorta of male aromatase-knockout mice: regulation of nitric oxide production by endogenous sex hormones in males. Circ Res 93, 1267-1271.
23. Labrie F (2010). DHEA, important source of sex steroids in men and even more in women. Prog Brain Res 182, 97-148.
24. Labrie F, Luu-The V, Bélanger A, Lin S-X, Simard J, Pelletier G & Labrie C (2005). Is dehydroepiandrosterone a hormone? J Endocrinol 187, 169-196.
25. Lam KK, Lee YM, Hsiao G, Chen SY & Yen MH (2006). Estrogen therapy replenishes vascular tetrahydrobiopterin and reduces oxidative stress in ovariectomized rats. Menopause 13, 294-302.
26. Liu D & Dillon JS (2004). Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor. Steroids 69, 279-289.
27. Liu D, Si H, Reynolds KA, Zhen W, Jia Z & Dillon JS (2007). Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Gαi protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression. Endocrinology 148, 3068-3076.
28. Medina MC, Souza LC, Caperuto LC, Anhê GF, Amanso AM, Teixeira VP, Bordin S, Carpinelli AR, Britto LR, Barbieri RL, Borella MI & Carvalho CRO (2006). Dehydroepiandrosterone increases β-cell mass and improves the glucose-induced insulin secretion by pancreatic islets from aged rats. FEBS Lett 580, 285-290.
29. Mendonça LS, Fernandes-Santos C & Mandarim-de-Lacerda CA (2007). Cardiac and aortic structural alterations due to surgically-induced menopause associated with renovascular hypertension in rats. Int J Exp Pathol 88, 301-309.
30. Mercuro G, Zoncu S, Saiu F, Mascia M, Melis GB & Rosano GMC (2004). Menopause induced by oophorectomy reveals a role of ovarian estrogen on the maintenance of pressure homeostasis. Maturitas 47, 131-138.
31. Nestler JE, Barlascini CO, Clore JN & Blackard WG (1988). Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metabol 66, 57-61.
32. Paredes-Carbajal MC, Juárez-Oropeza MA, Ortíz-Mendoza CM & Mascher D (1995). Effects of acute and chronic estrogenic treatment on vasomotor responses of aortic rings from ovariectomized rats. Life Sci 57, 473-486.
33. Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J, Brzyski R, Allison M, Ockene J, Sarto G & Rossouw JE (2009). Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Am J Epidemiol 170, 12-23.
34. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM & Ockene J (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333.
35. Schriock ED, Buffington CK, Hubert GD, Kurtz BR, Kitabchi AE, Buster JE & Givens JR (1988). Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding. J Clin Endocrinol Metabol 66, 1329-1331.
36. Squadrito F, Altavilla D, Squadrito G, Saitta A, Cucinotta D, Minutoli L, Deodato B, Ferlito M, Campo GM, Bova A & Caputi AP (2000). Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats. Cardiovasc Res 45, 454-462.
37. Strehlow K, Rotter S, Wassmann S, Adam O, Grohé C, Laufs K, Böhm M & Nickenig G (2003). Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 93, 170-177.
38. Tsuda M, Iwai M, Li JM, Li HS, Min LJ, Ide A, Okumura M, Suzuki J, Mogi M, Suzuki H & Horiuchi M (2005). Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress. Hypertension 45, 545-551.
39. Villareal DT & Holloszy JO (2004). Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA 292, 2243-2248.
40. Virdis A, Ghiadoni L, Pinto S, Lombardo M, Petraglia F, Gennazzani A, Buralli S, Taddei S & Salvetti A (2000). Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women. Circulation 101, 2258-2263.
41. Wassmann S, Bäumer AT, Strehlow K, Eickels MV, Grohé C, Ahlbory K, Rösen R, Böhm M & Nickenig G (2001). Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation 103, 435-441.
42. White RE (2002). Estrogen and vascular function. Vascul Pharmacol 38, 73-80.
43. Widder J, Pelzer T, Poser-Klein CV, Hu K, Jazbutyte V, Fritzemeier K, Hegele-Hartung C, Neyses L & Bauersachs J (2003). Improvement of endothelial dysfunction by selective estrogen receptor-α stimulation in ovariectomized SHR. Hypertension 42, 991-996.
44. Williams MR, Dawood T, Ling S, Dai A, Lew R, Myles K, Funder JW, Sudhir K & Komesaroff PA (2004). Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. J Clin Endocrinol Metab 89, 4708-4715.
45. Wong CM, Yao X, Au CL, Tsang SY, Fung KP, Laher I, Vanhoutte PM & Huang Y (2006). Raloxifene prevents endothelial dysfunction in aging ovariectomized female rats. Vascul Pharmacol 44, 290-298.
46. Wu S, Ruan Y, Yin M & Lai W (2007). Research on the age-related changes in the nitric oxide pathway in the arteries of rats and the intervention effect of dehydroepiandrosterone. Gerontology 53, 234-237.
47. Yorek MA, Coppey LJ, Gellett JS, Davidson EP, Bing X, Lund DD & Dillon JS (2002). Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function. Am J Physiol Endocrinol Metab 283, E1067-E1075.